Get Live Data

Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Ip Group Share Price
  4. Ip Group Share Regulatory News
  5. Transaction in Own Shares

Pin to quick picksIp Group Regulatory News (IPO)

Ip Group Information

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.25
Bid: 45.25
Ask: 45.30
Change: -0.60 (-1.31%)
Spread: 0.05 (0.11%)
Open: 46.75
High: 46.75
Low: 44.90
Prev. Close: 45.85
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

30 Apr 2024 07:00

RNS Number : 4908M
IP Group PLC
30 April 2024
 

Transaction in Own Shares

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), today announces that Numis Securities Limited (which is trading for these purposes as Deutsche Numis) ("Deutsche Numis"), purchased on behalf of IP Group the number of ordinary shares of 2 pence each on the London Stock Exchange as set out in the table below (the Repurchased Shares) pursuant to the IP Group share buyback programme announced on 18th December 2023 (the Buyback Programme).

Date of purchase:

29/04/2024

Number of ordinary shares purchased:

129,885

Highest price paid per ordinary share (GBp):

49.50

Lowest price paid per ordinary share (GBp): 

48.80

Volume weighted average price paid per ordinary share (GBp): 

49.0897

 

The Group will hold the Repurchased Shares in treasury. Following the above transaction, the Group holds 31,753,534 of its ordinary shares in treasury and has 1,063,188,005 ordinary shares in issue (including treasury shares). Therefore, the total number of ordinary shares with voting rights will be 1,031,434,471 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IP Group under the FCA's Disclosure Guidance and Transparency Rules.

 

IP Group will make further announcements following the completion of any additional purchases pursuant to the Buyback Programme.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Deutsche Numis on behalf of IP Group as part of the Buyback Programme.

 

Both aggregate data in respect of the Repurchased Shares as well as the individual purchases are set out below.

 

Aggregate information:

 

Issuer name and ISIN: IP Group plc (ISIN: GB00B128J450)

 

Date of purchases:

29/04/2024

Number of ordinary shares purchased:

129,885

Volume weighted average price (pence):

49.0897

 

Individual transactions:

 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Trading venue

5093

49.05

 10:28:58

XLON

5765

48.85

 10:32:36

XLON

6493

48.80

 10:32:45

XLON

5456

49.00

 13:24:40

XLON

536

49.15

 13:24:40

XLON

5341

49.00

 13:25:33

XLON

416

49.00

 13:25:37

XLON

5695

49.00

 13:25:37

XLON

1468

49.00

 13:27:33

XLON

758

49.00

 13:27:33

XLON

1090

49.00

 13:27:33

XLON

565

49.00

 13:27:33

XLON

1090

49.00

 13:27:33

XLON

565

49.00

 13:27:33

XLON

1090

49.00

 13:27:33

XLON

565

49.00

 13:27:33

XLON

6027

48.90

 13:33:43

XLON

779

48.80

 14:15:01

XLON

4593

48.80

 14:15:01

XLON

385

48.80

 14:15:01

XLON

2700

48.80

 14:15:01

XLON

3033

48.80

 14:15:01

XLON

712

49.10

 15:30:45

XLON

369

49.10

 15:30:45

XLON

712

49.10

 15:30:45

XLON

369

49.10

 15:30:45

XLON

712

49.10

 15:30:45

XLON

369

49.10

 15:30:45

XLON

712

49.10

 15:31:41

XLON

4146

49.10

 15:31:41

XLON

2087

49.10

 15:35:43

XLON

2077

49.10

 15:35:43

XLON

2077

49.10

 15:35:43

XLON

1064

49.10

 15:35:43

XLON

456

49.10

 15:35:43

XLON

380

49.10

 15:35:43

XLON

2077

49.10

 15:35:43

XLON

462

49.10

 15:35:43

XLON

602

49.10

 15:35:43

XLON

456

49.10

 15:35:43

XLON

380

49.10

 15:35:43

XLON

1905

49.05

 15:40:07

XLON

493

49.05

 15:40:07

XLON

423

49.05

 15:40:07

XLON

352

49.05

 15:40:07

XLON

280

49.10

 15:41:21

XLON

987

49.10

 15:41:21

XLON

352

49.10

 15:41:21

XLON

423

49.10

 15:41:21

XLON

633

49.10

 15:41:21

XLON

1125

49.10

 15:41:21

XLON

482

49.10

 15:41:21

XLON

401

49.10

 15:41:21

XLON

2170

49.10

 15:41:21

XLON

1125

49.10

 15:41:21

XLON

401

49.10

 15:41:21

XLON

482

49.10

 15:41:21

XLON

2799

49.10

 15:44:13

XLON

285

49.45

 15:55:31

XLON

2030

49.50

 15:58:16

XLON

1388

49.50

 15:58:16

XLON

1388

49.50

 15:58:16

XLON

1388

49.50

 15:58:16

XLON

5684

49.50

 15:58:30

XLON

5535

49.35

 16:06:06

XLON

793

49.15

 16:13:12

XLON

793

49.15

 16:14:16

XLON

3000

49.35

 16:16:17

XLON

1048

49.35

 16:16:48

XLON

3000

49.35

 16:16:48

XLON

3000

49.35

 16:18:48

XLON

499

49.35

 16:18:48

XLON

1586

49.20

 16:27:07

XLON

3913

49.20

 16:27:07

XLON

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Portland

Alex Donaldson

+44 (0) 7516 729702

 

Further information on IP Group is available on our website: www.ipgroupplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSZZGZDRLRGDZM
34567891011
Date   Source Headline
18th Oct 20217:00 amRNSTransaction in Own Shares
14th Oct 20216:27 pmRNSTransaction in Own Shares
13th Oct 20216:22 pmRNSTransaction in Own Shares
13th Oct 202111:36 amRNSDirector Declaration
13th Oct 20219:03 amRNSHolding(s) in Company
12th Oct 20216:20 pmRNSTransaction in Own Shares
12th Oct 20212:09 pmRNSDirector/PDMR Shareholding
12th Oct 20217:00 amRNSTransaction in Own Shares
11th Oct 20217:41 amRNSTransaction in Own Shares
8th Oct 20217:00 amRNSShare buyback programme
6th Oct 20217:00 amRNSBoard changes
5th Oct 20214:44 pmRNSHolding(s) in Company
30th Sep 20214:11 pmRNSTotal Voting Rights
30th Sep 20217:45 amRNSIP Group generates £84m from Oxford Nanopore IPO
27th Sep 202112:40 pmRNSDirector/PDMR Shareholding
23rd Sep 20213:57 pmRNSFurther re Scrip Dividend
16th Sep 20217:08 amRNSOxford Nanopore confirms ITF; MoU with Oracle
10th Sep 20215:21 pmRNSHolding(s) in Company
8th Sep 202110:53 amRNSDirector/PDMR Shareholding, SAYE scheme
19th Aug 202110:41 amRNSScrip Dividend Reference Price
12th Aug 20215:05 pmRNSDirector Declaration
5th Aug 20217:00 amRNSHalf-yearly results
27th Jul 20217:03 amRNSPortfolio company Artios Pharma raises $153m
22nd Jul 202111:30 amRNSNotice of Results
1st Jul 20217:00 amRNSTotal Voting Rights
28th Jun 20217:30 amRNSDirector/PDMR Shareholding
18th Jun 20219:52 amRNSDirector/PDMR Shareholding
17th Jun 20217:00 amRNSPortfolio company Apollo Therapeutics raises $145m
15th Jun 20218:00 amRNSFurther re Scrip Dividend
9th Jun 202111:29 amRNSResult of AGM
9th Jun 20217:00 amRNSAGM Statement
7th Jun 20217:00 amRNSPortfolio co Iksuda completes $42m financing round
28th May 20213:36 pmRNSDirector/PDMR Shareholding
28th May 202110:00 amRNSJoint venture with China Everbright to launch fund
27th May 20217:00 amRNSPortfolio co Pulmocide completes $92m Series C
26th May 20212:44 pmRNSUpdate on AGM
20th May 202110:01 amRNSScrip Dividend Reference Price
17th May 202112:44 pmRNSAdditional fair value gain of £20m
12th May 202112:08 pmRNSHolding(s) in Company
10th May 202111:15 amRNSInvestor webinars
6th May 20216:13 pmRNSNotice of AGM, Annual Report, Scrip Dividend
6th May 20215:55 pmRNSLTIP & DBSP awards; Director/PDMR shareholding
5th May 20217:00 amRNSPortfolio company Kuur acquired by Athenex
5th May 20217:00 amRNSPortfolio company Inivata acquired by NeoGenomics
4th May 20217:00 amRNSPortfolio company Oxford Nanopore raises £195m
7th Apr 202111:27 amRNSDirector/PDMR Shareholding
31st Mar 20219:15 amRNSHolding(s) in Company
30th Mar 20217:05 amRNSOxford Nanopore announces preparing for IPO in H2
26th Mar 202112:26 pmRNSEMA positive opinion for Diurnal's Chronocort
10th Mar 20217:00 amRNSAnnual Results
34567891011

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.